Literature DB >> 14517687

Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Stefan Höcht1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14517687     DOI： 10.1007/s00384-003-0521-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  30 in total

1.  Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

Authors:  C Cammà; M Giunta; F Fiorica; L Pagliaro; A Craxì; M Cottone
Journal:  JAMA       Date:  2000 Aug 23-30       Impact factor: 56.272

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  p53 and DCC immunohistochemistry in curative rectal cancer surgery.

Authors:  M Morgan; D Koorey; D Painter; M Findlay; R Newland; P Chapuis; M Solomon
Journal:  Int J Colorectal Dis       Date:  2002-10-25       Impact factor: 2.571

4.  Colorectal carcinoma in Poland in 1975 and 1995: not only more, but also different.

Authors:  Zbigniew Rudzki; Monika Zazula; Krzysztof Okoń; Jerzy Stachura
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

5.  Lymphoscintigraphy in patients with primary rectal cancer: the role of total mesorectal excision for primary rectal cancer--a lymphoscintigraphic study.

Authors:  Peter Sterk; Lothar Keller; Hans Jochims; Peter Klein; Friedrich Stelzner; Hans Peter Bruch; Uwe Markert
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

6.  Impact of age on the short-term postoperative outcome of patients undergoing surgery for colorectal carcinoma.

Authors:  Frank Marusch; Andreas Koch; Uwe Schmidt; Roland Zippel; Jörg Gastmeier; Klaus Ludwig; Sven Geissler; Matthias Pross; Ingo Gastinger; Hans Lippert
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

7.  Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.

Authors:  N Wolmark; H S Wieand; D M Hyams; L Colangelo; N V Dimitrov; E H Romond; M Wexler; D Prager; A B Cruz; P H Gordon; N J Petrelli; M Deutsch; E Mamounas; D L Wickerham; E R Fisher; H Rockette; B Fisher
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

8.  The pathological assessment of mesorectal excision: implications for further treatment and quality management.

Authors:  P Hermanek; P Hermanek; W Hohenberger; M Klimpfinger; F Köckerling; T Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2003-02-14       Impact factor: 2.571

9.  Improvement in irritable bowel syndrome following ano-rectal surgery.

Authors:  Bernard V Palmer; W John Lockley; Robert B Palmer; Elena Kulinskaya
Journal:  Int J Colorectal Dis       Date:  2002-03-07       Impact factor: 2.571

10.  Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Authors:  J E Krook; C G Moertel; L L Gunderson; H S Wieand; R T Collins; R W Beart; T P Kubista; M A Poon; W C Meyers; J A Mailliard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.